Nuwellis, Inc. ( (NUWE) ) has released its Q2 earnings. Here is a breakdown of the information Nuwellis, Inc. presented to its investors.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Nuwellis, Inc. is a commercial-stage medical technology company focused on providing innovative solutions for fluid overload patients, primarily through its Aquadex SmartFlow system. The company operates in the medical device sector and is headquartered in Minneapolis, Minnesota.
In its second quarter of 2025, Nuwellis reported a decline in revenue to $1.7 million from $2.2 million in the same quarter of the previous year. This decrease was attributed to a temporary product backorder caused by an industry-wide sterilization delay. Despite this setback, the company remains committed to its strategic focus on pediatric and cardiac surgery care.
Key financial metrics for the quarter included a gross margin of 55.5%, down from 67.2% in the previous year, and an operating loss of $2.9 million, compared to $2.3 million in Q2 2024. The company also reported a net loss of $12.6 million, significantly higher than the $7.7 million loss in the same period last year. On a positive note, Nuwellis successfully raised $5 million in capital and expanded its pediatric center network to 47 centers.
Looking ahead, Nuwellis is focused on executing its strategy to drive long-term growth, with a particular emphasis on its core markets. The management remains optimistic about the company’s future prospects, despite the challenges faced in the second quarter.